Glyxambi 10/5 mg; Glyxambi 25/5 mg


Film-coated tablets
scheduling status
S4
registration number
55/21.2/0030; 55/21.2/0031
What Glyxambi 10/5 mg; Glyxambi 25/5 mg contains
GLYXAMBI 10/5 mg contains 10 mg empagliflozin and 5 mg linagliptin. GLYXAMBI 25/5 mg contains 25 mg empagliflozin and 5 mg linagliptin.
other ingredients
Each film-coated tablet of GLYXAMBI 10/5 mg contains the following inactive ingredients: mannitol (107 mg/tablet), pregelatinised maize starch, maize starch, copovidone, crospovidone, purified talc, magnesium stearate, hypromellose, titanium dioxide, macrogol, iron oxide yellow. Each film-coated tablet of GLYXAMBI 25/5 mg contains the following inactive ingredients: mannitol (92 mg/tablet), pregelatinised maize starch, maize starch, copovidone, crospovidone, purified talc, magnesium stearate, hypromellose, titanium dioxide, macrogol, iron oxide red.
Therapeutic classification
A10BD19.
© 2026 SAHPRA. ALL RIGHTS RESERVED